Skip to main content Accessibility help
×
Preparing your materials

Policy on prior publication

When authors submit manuscripts to this journal, these manuscripts should not be under consideration, accepted for publication or in press within a different journal, book or similar entity, unless explicit permission or agreement has been sought from all entities involved. However, deposition of a preprint on the author’s personal website, in an institutional repository, or in a preprint archive shall not be viewed as prior or duplicate publication. Authors should follow the Cambridge University Press Preprint Policy regarding preprint archives and maintaining the version of record. 

Article Types

The Editors invite papers in one of three categories: Research Papers, Development Papers, and Short Reports.

Research papers: Quantitative and Qualitative Research

PHCR&D welcomes papers that present primary research (qualitative, quantitative or mixed method) or disseminate evidence, including systematic reviews and meta-analysis. All papers should make clear the relevance of their research to an international PHC audience and implications for policy and practice.

Concise, clear writing is one of the criteria by which editors and reviewers evaluate submissions. Please supply a structured abstract (maximum 300 words) for your article; to include the following 4 headings: aim, background, methods, and findings. PHCR&D will take into consideration the registration of RCTs in a public trials registry, as described by the International Committee of Medical Journal Editors (See www.icmje.org). For randomized clinical trials, concordance with CONSORT guidelines published by EQUATOR network including a CONSORT flow diagram and checklist.  

Articles should normally be up to 5000 words long. We will consider linked papers.

Development papers

The Editors are keen to encourage papers from all areas of PHC which address the developmental aspects of work which is informing both practice and the research agenda. This is seen as an area which is often overlooked in peer-reviewed journals, partly because development is not recognised as ‘real research’, and partly because we have been limited by the criteria which are usually used to judge research but are not appropriate for development.

To ensure that we can publish high-quality Development Papers, we have drawn upon notions of validity which have been adopted widely for qualitative research. For example, the concept of trustworthiness of information and the need to provide an ‘audit trail’ may be used rather than the concept of validity. Additionally, the concept of ‘transferability’ needs to be considered rather than 'generalisability'.

Development Papers need to be defined as such by the authors, but the Editors will also make a decision about the status of a paper including criteria such as whether it:

  • discusses a local issue;
  • discusses the introduction of an innovation;
  • discusses matters relating to reflective practice or developing practice;
  • relates to issues of learning and dissemination in PHC;
  • informs a new area for research;
  • addresses issues of evaluation.


Authors should note that when reviewing such a paper we ask reviewers to consider the following questions:

  1. 1. How has the author drawn on existing evidence to inform the discussion of the development? It is expected that Development Papers should make sufficient use of the literature and background theory to inform their thinking, as well as evidence from other sources such as expert advice.
  2. 2. What was the rationale for the development? Is this clearly argued?
  3. 3. How sufficient is the description of the development? The context should be discussed in some detail, including any policy context in which it might be embedded.
  4. 4. Where case study examples or scenarios are used, how are these documented? Is there enough information to make a trustworthy judgement of the development work? Are examples appended? In other words, the reader should be convinced that this is not just evangelism.
  5. 5. Is the discussion of the development conducted in light of the existing evidence?
  6. 6. How are conclusions drawn from the development? What message is the author trying to convey? Is this achieved? Are there key points for further research or practice development to be undertaken?
  7. 7. Does the author offer a critical analysis of the development which recognises limitations as well as strengths?
  8. 8. Has the development been evaluated? If so, are the methods appropriately discussed? If not, is a rationale provided or plans for future evaluation?
  9. 9. Referencing is as important in a Development Paper as in research (see guidelines below).

Development papers should be no more than 5000 words in length excluding references.

Short Reports

PHCR&D welcomes Short Reports. These are invited from all areas of primary healthcare research and development. Short Reports will typically report primary research that the authors feel in insufficient in scope for a full paper. For example Short Reports may describe pilot studies, exploratory studies, scoping studies, brief narrative reviews or smaller research projects conducted with fewer resources and in less time than those normally reported in full papers. PHCR&D wish to receive Short Reports from all members of the primary health care community but are particularly keen to attract Short Reports from relatively inexperienced members of the research community, including medical students conducting intercalated degrees, masters students, and professionals conducting research placements.

Brief reports should be between 1500 and 2000 words in length. They need not include a structured abstract, but a summary of the paper in approximately 150 words will facilitate the editorial and review process. Normally, brief reports will comprise an introduction and/or background to the work, a brief explanation of any methods employed, results (tables or figures are preferred) and a discussion of the implications of the work. Prospective contributors are directed to the ‘Detailed Manuscript Preparation Guidelines section for details on how to prepare their manuscript. 

Protocol Papers

PHCR&D welcomes papers that present study protocols related to primary care research. All papers should make clear the relevance of their rationale, methodology including description of intervention, estimated number of participants, subject selection, primary and secondary outcomes. Specifically for randomized clinical trials, it is recommended to use the Recommendations for Interventional Trials (SPIRIT) and for systematic review and meta- analysis protocols Preferred Reporting Items for Systematic Review and Meta -Analysis Protocols (PRISMA-P) created by EQUATOR network.

Please supply a structured abstract (maximum 300 words) for your article; to include the following 4 headings: aim, background and methods and discussion.

Articles should normally be up to 4000 words long. 

Detailed manuscript preparation guidelines

Authors whose first language is not English are requested to have their manuscript checked carefully for linguistic corrections before submission. We list a number of third-party services specialising in language editing and/or translation, and suggest that authors contact as appropriate. Use of any of these services is voluntary, and at the author's own expense.

All types of manuscripts are expected to be in concordance with EQUATOR network guidelines summarized below:

Randomised trials

CONSORT

Observational studies

STROBE

Systematic reviews

PRISMA

Study protocols

SPIRIT

PRISMA-P

Diagnostic/prognostic studies

STARD

TRIPOD

Case reports

CARE

Clinical practice guidelines

AGREE

RIGHT

Qualitative research

SRQR

COREQ

Quality improvement studies

SQUIRE

CHEERS

Besides EQUATOR guides (www.icmje.org ), Authors are strongly encouraged to use CRISP (Improving the Reporting of Primary Care Research: Consensus Reporting Items for Studies in Primary Care—the CRISP Statement). CRISP is the first reporting guideline by and for primary care research. Detailed information and checklist is available at this link: https://crisp-pc.org/


Microsoft Word is the preferred software. When preparing your paper:

  • Use the minimum formatting;
  • Roman, bold and italic type can be used, but only one typeface and font;
  • Capitals should be used only where they are to appear in the finished text;
  • The text should be ranged left and unjustified, with hyphenation cancellation;
  • Indents, underlining and tabs should be avoided unless absolutely necessary;
  • Heading and paragraphs should be separated by two carriage returns;
  • There should only be one space between words and only one space after punctuation;
  • Avoid using more than three levels of heading;
  • Avoid excessive capitalization;
  • Use italics for emphasis sparingly.


Give the title of the paper and a running title if the main title is longer than 12 words or 50 characters. On the separate Title Page authors should include: their first and family name; their post at the time they did the work; their current appointments and qualifications; the name and address of the author to whom correspondence and proof should be sent, together with email and telephone numbers.

Please ensure that your files are uploaded in the following order:

For Original Submissions:
  1. 1. Author covering letter (this should be anonymous with no identifying information)
  2. 2. Title Page containing all author contact information and funding information
  3. 3. Manuscript file (anonymised) containing the title of the work, Structured Abstract and Keywords followed by the main body of the paper prepared as per the instructions below
  4. 4. Figure captions (mandatory if figures are included)
  5. 5. Figures (one file per figure)
  6. 6. Tables as a single word document
  7. 7. Any Supplementary Material 
For Revised Submissions
  1. 1. Authors response to reviewers comments (this should be anonymous)
  2. 2. Title Page containing all author contact information and funding information.
  3. 3. Tracked Changes Manuscript file (anonymised) containing the title of the work, Structured Abstract and Keywords followed by the main body of the paper showing all additions and omissions.
  4. 4. Figure captions (mandatory if figures are included)
  5. 5. Figures (one file per figure)
  6. 6. Tables as a single word document
  7. 7, Any Supplementary Material 
  8. 8. A blank separator page which can be downloaded here
  9. 9. Clean Manuscript file (anonymised) where all changes have been incorporated into the file and tracking has been turned off.
  10. 10. The License to Publish Form available here.

All pages must be numbered.

Abbreviations and measurements

Abbreviations should be kept to a minimum and must be clearly defined when used first time. Abbreviations should be typed with no full point.

For numbers, adopt a rule that all numbers under 10 should be written as words except when attached to a unit of quantity (e.g.1 mm or 3 kg), and that numbers of over 10 should be written as digits except at the beginning of a sentence.

Scientific measurements should be given in SI units, but blood pressure should be expressed as mmHg and haemoglobin as g/dl.

Generic names should be used for drugs. Authors should be aware of different names and availability in the UK, North America and Australia, and give alternative names of drugs in the text.

Tables and figures

No artwork should be included in text files. Any artwork should be in either TIFF or EPS format, and saved as individual files per Figure. Tables and Figures should be submitted separately from the text and legendary illustrations should also be separate.

Care should be taken that all statistical methods are relevant and that it is clear which methods were used. Any statistical tests should be reported as well as the p value.

Authors must obtain permission from the publishers to reproduce all Tables and Figures that have been previously published. As a rule it is also necessary to obtain permission for single passages of prose exceeding 250 words, or scattered passages totalling 400 words from any one work. Please supply the Editor with full information for any cited work, including author name, date published, publisher, and page references. EU copyright extends to 70 years after the death of an author, or 70 years after publication of scholarly edition, whichever is longer. Special considerations apply for clinical photographs of patients. Please contact the Editor if you wish to include them in your paper.

Please include the following sections at the end of your paper, before the References:

Acknowledgements You may acknowledge individuals or organisations that provided advice, support (non- financial). Formal financial support and funding should be listed in the following section.

Financial Support Please provide details of the sources of financial support for all authors, including grant numbers. For example, ‘‘This work was supported by the Medical research Council (grant number XXXXXXX)’’. Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with ‘‘and’’ before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors’ initials. For example, ‘‘This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)’’. Where no specific funding has been provided for research, please provide the following statement: ‘‘This research received no specific grant from any funding agency, commercial or not-for-profit sectors.’’

Conflict(s) of Interest Please provide details of all known financial, professional and personal relationships with the potential to bias the work. Where no known conflicts of interest exist, please include the following statement: ‘‘None.’’

Ethical Standards Where research involves human and/or animal experimentation, the following statements should be included (as applicable): ‘‘The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guidelines on human experimentation (please name) and with the Helsinki Declaration of 1975, as revised in 2008.’’ and ‘‘The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals (please name).’’

A statement should also be included regarding informed consent e.g. “Written (or Verbal) informed consent was obtained from all subjects/patients.” Where verbal consent was obtained this must be followed by a statement such as: “Verbal consent was witnessed and formally recorded”. Where results were obtained from sources such as staff surveys where is it not deemed essential to receive informed consent, this should be qualified.

For more information on the ethical standards and procedures of Cambridge Core, please visit www.cambridge.org/core/services/authors/publication-ethics.

References

Papers should be prepared in accordance to the Harvard system arranged in alphabetical order by the first letter of the surname of the author. Journal articles and titles should be referred to in full. For example:

Kendall, S. and Bloomfield, L. 2005: Developing and validating a tool to measure parenting self-efficacy. Journal of Advanced Nursing 51, (2), 174-181.

Silverman, D. 1993: Interpreting Qualitative Data. Methods for Analysing Talk, Text and Interaction. London: SAGE Publications.

Slater, J. 1996: Measuring Occupational Stress in Primary Health Care Teams. Ch 20: 192-99. IN: Bryar, R. and Bytheway, B. (Eds) Changing Primary Health Care. The Teamcare Valleys Experience. Oxford: Blackwell Science.

In the text when referring to more than one source please list these in the order of oldest source first e.g. (Silverman, 1993; Slater, 1996; Kendall and Bloomfield, 2005)

When using quotations please include the page number of the quotation e.g. (Silverman, 1993:15)

English language editing services 

Authors, particularly those whose first language is not English, may wish to have their English-language manuscripts checked by a native speaker before submission. This step is optional, but may help to ensure that the academic content of the paper is fully understood by the Editor and any reviewers.  

In order to help prospective authors to prepare for submission and to reach their publication goals, Cambridge University Press offers a range of high-quality manuscript preparation services, including language editing. You can find out more on our language services page.

Please note that the use of any of these services is voluntary, and at the author's own expense. Use of these services does not guarantee that the manuscript will be accepted for publication, nor does it restrict the author to submitting to a Cambridge-published journal. 

Competing Interests

All authors must include a competing interest declaration in their main manuscript file. This declaration will be subject to editorial review and may be published in the article. 

Competing interests are situations that could be perceived to exert an undue influence on the content or publication of an author’s work. They may include, but are not limited to, financial, professional, contractual or personal relationships or situations. 

If the manuscript has multiple authors, the author submitting must include competing interest declarations relevant to all contributing authors. 

Example wording for a declaration is as follows: “Competing interests: Author 1 is employed at organisation A, Author 2 is on the Board of company B and is a member of organisation C. Author 3 has received grants from company D.” If no competing interests exist, the declaration should state “Competing interests: The author(s) declare none”. 

Authorship and contributorship

All authors listed on any papers submitted to this journal must be in agreement that the authors listed would all be considered authors according to disciplinary norms, and that no authors who would reasonably be considered an author have been excluded. For further details on this journal’s authorship policy, please see this journal's publishing ethics policies.

Use of artificial intelligence (AI) tools

We acknowledge the increasing use of artificial intelligence (AI) tools in the research and writing processes. To ensure transparency, we expect any such use to be declared and described fully to readers, and to comply with our plagiarism policy and best practices regarding citation and acknowledgements. We do not consider artificial intelligence (AI) tools to meet the accountability requirements of authorship, and therefore generative AI tools such as ChatGPT and similar should not be listed as an author on any submitted content. 

In particular, any use of an AI tool: 

  • to generate images within the manuscript should be accompanied by a full description of the process used, and declared clearly in the image caption(s) 
  • to generate text within the manuscript should be accompanied by a full description of the process used, include appropriate and valid references and citations, and be declared in the manuscript’s Acknowledgements. 
  • to analyse or extract insights from data or other materials, for example through the use of text and data mining, should be accompanied by a full description of the process used, including details and appropriate citation of any dataset(s) or other material analysed in all relevant and appropriate areas of the manuscript 
  • must not present ideas, words, data, or other material produced by third parties without appropriate acknowledgement or permission 

Descriptions of AI processes used should include at minimum the version of the tool/algorithm used, where it can be accessed, any proprietary information relevant to the use of the tool/algorithm, any modifications of the tool made by the researchers (such as the addition of data to a tool’s public corpus), and the date(s) it was used for the purpose(s) described. Any relevant competing interests or potential bias arising as a consequence of the tool/algorithm’s use should be transparently declared and may be discussed in the article. 

Author affiliations

Author affiliations should represent the institution(s) at which the research presented was conducted and/or supported and/or approved. For non-research content, any affiliations should represent the institution(s) with which each author is currently affiliated. 

For more information, please see our author affiliation policy and author affiliation FAQs.

ORCID

We encourage authors to identify themselves using ORCID when submitting a manuscript to this journal. ORCID provides a unique identifier for researchers and, through integration with key research workflows such as manuscript submission and grant applications, provides the following benefits:

  • Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you have authored.
  • Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
  • Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.

See our ORCID FAQs for more information. If you don’t already have an iD, you can create one by registering directly at https://ORCID.org/register.

ORCIDs can also be used if authors wish to communicate to readers up-to-date information about how they wish to be addressed or referred to (for example, they wish to include pronouns, additional titles, honorifics, name variations, etc.) alongside their published articles. We encourage authors to make use of the ORCID profile’s “Published Name” field for this purpose. This is entirely optional for authors who wish to communicate such information in connection with their article. Please note that this method is not currently recommended for author name changes: see Cambridge’s author name change policy if you want to change your name on an already published article. See our ORCID FAQs for more information. 

Supplementary materials

Material that is not essential to understanding or supporting a manuscript, but which may nonetheless be relevant or interesting to readers, may be submitted as supplementary material. Supplementary material will be published online alongside your article, but will not be published in the pages of the journal. Types of supplementary material may include, but are not limited to, appendices, additional tables or figures, datasets, videos, and sound files.

Supplementary materials will not be typeset or copyedited, so should be supplied exactly as they are to appear online. Please see our general guidance on supplementary materials for further information.

Where relevant we encourage authors to publish additional qualitative or quantitative research outputs in an appropriate repository, and cite these in manuscripts.

Author Hub

You can find guides for many aspects of publishing with Cambridge at Author Hub, our suite of resources for Cambridge authors.